IP Library Granted Patent US 10,159,540
Granted Patent B2
US 10,159,540 · App. 15/472,561 · Granted Dec 25, 2018

Securement for a surgical site marker and deployment device for same

Inventors: Joseph L. Mark (Indianapolis, IN); Zachary R. Nicoson (Indianapolis, IN)
Assignee: SUROS SURGICAL SYSTEMS, INC.
A61B90/39A61M5/007A61B2017/3441A61B2090/3908
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,159,540
App. No.
15/472,561
Granted
Dec 25, 2018
Kind
B2
Abstract

A method of securing a biopsy marker within a biopsy site includes depositing a marker element within a biopsy site and fixing the marker element within the biopsy site by injecting a securing agent within the biopsy site. Delivery devices for delivering the securing agent to the biopsy site are also disclosed.

Claims (29)

1. An apparatus for deploying a securing agent in a biopsy site, comprising:

an elongate body having a proximal end, a distal end, and a lumen extending between the proximal and distal ends;

a dividing element disposed in the lumen so as to separate a proximal portion of the lumen from a distal portion of the lumen; and

a securing agent disposed in the distal portion of the lumen, wherein the securing agent comprises a material that accelerates clotting to substantially limit migration of a marker from the biopsy site,

wherein the dividing element is configured to allow a fluid to pass from the proximal portion of the lumen into the distal portion, while the securing agent is substantially prevented from passing proximally through the dividing element.

2. The apparatus of claim 1 , wherein the securing agent is in a form selected from the group consisting of slurry, gel powder, pellet, and plug.

3. The apparatus of claim 1 , wherein the dividing element comprises a semi-permeable filter.

4. The apparatus of claim 3 , wherein the filter comprises an open cell foam material.

5. The apparatus of claim 1 , further comprising a normally closed valve proximate the distal end opening of the elongate body, wherein the valve is biased to prevent substances external of the elongate body from entering the lumen through the distal end opening, while allowing at least a portion of the securing agent to pass through the valve when subjected to a fluid force.

6. The apparatus of claim 5 , wherein the normally closed valve is disposed in the lumen proximate the distal end opening of the elongate body.

7. The apparatus of claim 5 , wherein the normally closed valve is disposed external to the lumen proximate the distal end opening of the elongate body.

8. The apparatus of claim 5 , wherein the normally closed valve comprises a duckbill valve.

9. The apparatus of claim 1 , wherein the fluid comprises air.

10. An apparatus for deploying a securing agent in a biopsy site, comprising:

an elongate body having a proximal end, a distal end, and a lumen extending between the proximal and distal ends;

a filter element disposed in the lumen so as to separate a proximal portion of the lumen from a distal portion of the lumen; and

a securing agent disposed in the distal portion of the lumen, wherein the securing agent comprises a material that accelerates clotting to substantially limit migration of the marker from the biopsy site,

wherein the filter element is configured to allow a fluid to pass from the proximal portion of the lumen into the distal portion, while the securing agent is substantially prevented from passing proximally through the filter element.

11. The apparatus of claim 10 , wherein the securing agent is in a form selected from the group consisting of slurry, gel powder, pellet, and plug.

12. The apparatus of claim 10 , wherein the filter element comprises a semi-permeable filter.

13. The apparatus of claim 12 , wherein the filter comprises an open cell foam material.

14. The apparatus of claim 10 , further comprising a duckbill valve disposed in the lumen proximate the distal end opening of the elongate body, wherein the valve is biased to prevent substances external of the elongate body from entering the lumen through the distal end opening, while allowing the securing agent to pass through the valve when subjected to a fluid force.

15. An apparatus for deploying a securing agent in a biopsy site, comprising:

an elongate body having a proximal end, a distal end, and a lumen extending between the proximal and distal ends;

a semi-permeable filter disposed in the lumen so as to separate a proximal portion of the lumen from a distal portion of the lumen;

a securing agent disposed in the distal portion of the lumen, wherein the securing agent comprises a material that accelerates clotting to substantially limit migration of the marker from the biopsy site, wherein the filter is configured to allow a fluid to pass from the proximal portion of the lumen into the distal portion, while the securing agent is substantially prevented from passing proximally through the filter; and

a duckbill valve disposed in the lumen proximate the distal end opening of the elongate body, wherein the valve is biased to prevent substances external of the elongate body from entering the lumen through the distal end opening, while allowing the securing agent to pass through the valve when subjected to a fluid force.

16. The apparatus of claim 15 , wherein the securing agent is in a form selected from the group consisting of slurry, gel powder, pellet, and plug.

17. The apparatus of claim 15 , wherein the filter comprises an open cell foam material.

Assignments (5)
RELEASE OF SECURITY INTEREST RECORDED AT REEL/FRAME 042055/0241 Recorded Apr 23, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: HOLOGIC, INC.; GEN-PROBE INCORPORATED; SUROS SURGICAL SYSTEMS, INC.
Reel/Frame 075515/0001 →
SECURITY INTEREST Recorded Apr 8, 2026
From: BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; CYTYC CORPORATION; SUROS SURGICAL SYSTEMS, INC.; GYNESONICS, INC.; BOLDER SURGICAL, LLC; FAXITRON BIOPTICS, LLC; HEALTH BEACONS, INC.; HOLOGIC, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 075462/0440 →
SECURITY INTEREST Recorded Oct 14, 2019
From: HOLOGIC, INC.; CYNOSURE, LLC; CYTYC CORPORATION; FAXITRON BIOPTICS, LLC; FOCAL THERAPEUTICS, INC.; GEN-PROBE INCORPORATED
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 050719/0701 →
SECURITY INTEREST Recorded Apr 19, 2017
From: HOLOGIC, INC.; GEN-PROBE INCORPORATED; SUROS SURGICAL SYSTEMS, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 042055/0241 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 29, 2017
From: MARK, JOSEPH L.; NICOSON, ZACHARY R.
To: SUROS SURGICAL SYSTEMS, INC.
Reel/Frame 041783/0420 →
Continuity (5)
Continuation 14044611 · Oct 2, 2013
Continuation 13416899 · Mar 9, 2012
Continuation 12113625 · May 1, 2008
Provisional Application 60915275 · May 1, 2007
Related Publication 20170196653A1 · Jul 13, 2017